Here is the latest shareholding Pattern of HESTER BIOSCIENCES. For more details, see the HESTER BIOSCIENCES financial fact sheet and HESTER BIOSCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 44.28 | 44.28 | 44.28 | 44.28 | 44.28 | 44.28 | 44.28 | 44.28 | |
Foreign Promoters | % | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | |
Total Promoters | % | 53.73 | 53.73 | 53.73 | 53.73 | 53.73 | 53.73 | 53.73 | 53.73 | |
Mutual Funds | % | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.72 | 0.00 | 0.45 | 0.45 | 0.45 | 0.42 | 0.43 | 0.43 | |
Other | % | 0.01 | 0.62 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.76 | 0.65 | 0.48 | 0.45 | 0.45 | 0.42 | 0.43 | 0.43 | |
Bodies Corporate | % | 3.04 | 3.32 | 3.04 | 2.95 | 2.87 | 3.17 | 3.06 | 3.00 | |
Individuals | % | 32.61 | 32.74 | 32.96 | 33.02 | 33.36 | 33.19 | 33.30 | 33.33 | |
NRIs/OCBs | % | 6.06 | 6.02 | 5.99 | 6.04 | 5.99 | 6.09 | 6.06 | 5.99 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 3.80 | 3.53 | 3.79 | 3.81 | 3.60 | 3.40 | 3.42 | 3.52 | |
Total Non-Institution | % | 45.51 | 45.61 | 45.78 | 45.82 | 45.82 | 45.85 | 45.84 | 45.84 | |
Total Public | % | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.